Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cabaletta Bio, Inc. - Common Stock (NQ:CABA)

1.968 +0.097 (+5.21%)
Streaming Delayed Price Updated: 10:55 AM EDT, Jun 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cabaletta Bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Cabaletta Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
From Cabaletta Bio
Via GlobeNewswire
Cabaletta Bio Appoints Global Commercial Leader Shawn Tomasello to Board of Directors
From Cabaletta Bio
Via GlobeNewswire
Why Shares of Cabaletta Bio Are Up Tuesday
The biotech stock rose after an analyst upgrade. 
Via The Motley Fool
Analyst Sees Positive Outlook For Cabaletta Bio: Sees Promise In CAR-T Therapy Approach
Guggenheim Securities initiated coverage of Cabaletta Bio Inc (NASDAQ: CABA) with a Buy rating and  
Via Benzinga
Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 7/18
Via Investor Brand Network
Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 7/12
Via Investor Brand Network
Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 5/18
Via Investor Brand Network
Recap: Cabaletta Bio Q1 Earnings
Via Benzinga
Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 5/2
Via Investor Brand Network
Benzinga's Top Ratings Upgrades, Downgrades For July 18, 2023
Via Benzinga
SPOT Stock Alert: Spotify Moves on Analyst Upgrade
Spotify (SPOT) stock is moving on Wednesday following an upgrade and price target from Wolfe Research analyst Zach Morrissey. 
Via InvestorPlace
Where Cabaletta Bio Stands With Analysts
Via Benzinga
Why Is Cabaletta Bio (CABA) Stock Down 8% Today?
Cabaletta Bio (CABA) stock is falling on Wednesday following news of insider selling at the targeted cell therapy company. 
Via InvestorPlace
Why Advanced Health Intelligence Shares Are Trading Higher By 111%; Here Are 20 Stocks Moving Premarket
Gainers Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares gained 110.8% to $1.56 in pre-market trading after the company signed a Letter of Intention with UAE-Based e-script medicine management... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to start off the day with a breakdown of the biggest pre-market stock movers worth watching on Wednesday morning! 
Via InvestorPlace
La-Z-Boy, FedEx And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures traded mixed this morning. Here are some big stocks recording losses in today’s pre-market trading session. Zura Bio Limited (NASDAQ: ZURA) shares tumbled 7.7% to $11.82 in... 
Via Benzinga
Cabaletta Bio to Present at the Jefferies Healthcare Conference
From Cabaletta Bio
Via GlobeNewswire
Cabaletta Bio Announces Closing of $100 Million Public Offering of Common Stock, Including Full Exercise of Option to Purchase Additional Shares
From Cabaletta Bio
Via GlobeNewswire
Cabaletta Bio Announces Pricing of Public Offering of Common Stock
From Cabaletta Bio
Via GlobeNewswire
Cabaletta Bio Announces Proposed Public Offering of Common Stock
From Cabaletta Bio
Via GlobeNewswire
Why RH Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers GD Culture Group Limited (NASDAQ: GDC) shares climbed 121.9% to $9.63 after gaining over 8% on Monday. GD Culture recently announced an $11.55 million registered direct offering. 
Via Benzinga
Stratasys, Navitas Semiconductor, United Insurance And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded mostly lower, with the Dow Jones dropping around 200 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Cabaletta Bio Receives FDA Clearance of IND Application for CABA-201 for Treatment of Myositis
From Cabaletta Bio
Via GlobeNewswire
Cabaletta Bio Reports First Quarter 2023 Financial Results and Provides Business Update
From Cabaletta Bio
Via GlobeNewswire
Cabaletta Bio to Present at the American Society of Gene and Cell Therapy 26th Annual Meeting
From Cabaletta Bio
Via GlobeNewswire
Cabaletta Bio Receives FDA Fast Track Designation for CABA-201
From Cabaletta Bio
Via GlobeNewswire
Cabaletta Bio to Present at the H.C. Wainwright BioConnect Investor Conference at NASDAQ
From Cabaletta Bio
Via GlobeNewswire
Cabaletta Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference
From Cabaletta Bio
Via GlobeNewswire
Why Y-mAbs Therapeutics Shares Are Trading Higher By 50%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) climbed 49.9% to $4.93 after the company posted a profit for the fourth quarter. 
Via Benzinga
Cabaletta Bio Receives FDA Clearance of IND Application for CABA-201 for Treatment of Systemic Lupus Erythematosus
From Cabaletta Bio
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.